Background: Chronic obstructive pulmonary disease (COPD) is a progressive respiratory
illness that is a leading cause of morbidity and mortality globally. It has a considerable impact on
the patient's capacity to work and quality of life. Dyspnea is one of the most common health issues
among those suffering from chronic obstructive pulmonary disease. The study aimed to compare
the effect of acupressure versus pursed-lip breathing intervention on dyspnea and pulmonary
function among chronic obstructive pulmonary disease patients. Design: This study was carried out
using a quasi-experimental design. Sample: A purposive sample of 100 adult patients was selected
and divided into two groups, one for acupressure (n=50) and the other for pursed-lip breathing
(n=50). Setting: The study was conducted in the Inpatient chest Unit at Beni-Suef University
Hospital. Tools of data collection included (1) Patient's demographic questionnaire, (2)
Measurement of pulmonary function tests sheet, (3) Measurement of the sensation of breathlessness
(dyspnea) by Dyspnea index, (4) The 3-min step test, and (5) Assessment of health status in chronic
obstructive pulmonary disease patient questionnaire. Results: It was discovered that, as compared
to pre-intervention, there was a significant improvement and increase in forced vital capacity FVC,
forced expiratory volume in one second FEV 1, and FEV1 /FVC. More than the acupressure group,
the dyspnea index decreased after pursed-lip breathing. The CAT score questionnaire improved both
before and after the intervention. Pre and post 3min step test post-intervention, the dyspnea index
was much lower. Conclusion: Pursued-lip breathing was found to be beneficial in alleviating
dyspnea in COPD patients, but acupressure had just a little effect. The COPD Assessment Test
Questionnaire (CAT) score questionnaire, as well as the Dyspnea index in COPD patients, improved.
Recommendation: Applying pursed-lip breathing intervention is recommended to control dyspnea
and improve ventilatory functions among COPD patients.